Edwards Lifesciences Corp (EW)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	1,509,300	1,596,800	1,620,900	1,583,400	1,534,100	1,581,800	1,565,800	1,698,100	1,748,500	1,675,100	1,663,000	1,745,600	1,690,300	1,667,300	1,634,800	923,000	897,600	857,000	793,500	1,230,700
Revenue (ttm)	US$ in thousands	5,724,300	5,872,600	5,999,100	6,143,400	6,004,800	5,819,000	5,657,100	5,500,800	5,382,400	5,363,800	5,355,000	5,357,100	5,232,500	5,094,500	4,925,200	4,474,200	4,386,300	4,368,700	4,321,800	4,483,700
Operating profit margin		26.37%	27.19%	27.02%	25.77%	25.55%	27.18%	27.68%	30.87%	32.49%	31.23%	31.06%	32.58%	32.30%	32.73%	33.19%	20.63%	20.46%	19.62%	18.36%	27.45%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,509,300K ÷ $5,724,300K
= 26.37%

The operating profit margin for Edwards Lifesciences Corp has displayed fluctuations over the analyzed periods. From March 2020 to December 2020, the margin increased steadily from 27.45% to 20.46%. Subsequently, there was a notable improvement in the margin, reaching 33.19% by June 2021, which was the highest point in the analyzed period. The margin remained relatively stable around the 30% range for the following quarters until December 2022, where it peaked at 32.49%. However, from March 2023 onwards, the operating profit margin experienced a declining trend, decreasing to 25.55% by December 2023. This downward trend continued into 2024, with the margin oscillating between 25% and 27% range, reaching 26.37% by December 2024. Overall, despite some fluctuations, the operating profit margin of Edwards Lifesciences Corp has shown a generally positive performance over the analyzed period.